Trials / Completed
CompletedNCT02049242
Uterine Tourniquet at Open Myomectomy
Triple Tourniquet vs. Single Tourniquet at Open Myomectomy to Reduce Blood Loss: A Prospective Randomised Controlled Trials
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Ataturk University · Academic / Other
- Sex
- Female
- Age
- 16 Years – 48 Years
- Healthy volunteers
- Accepted
Summary
The aim of study is to compare triple tourniquet vs. single tourniquet to reduce blood loss at open myomectomy.
Detailed description
Single tourniquet is applied to uterine isthmus to occlude uterine arteries. Triple tourniquet is applied to both infundibulopelvic ligaments and uterine isthmus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | triple tourniquet | Triple tourniquet consist of two tourniquet applied both infundibulopelvic ligaments and one uterine isthmus to occlude the left and right ovarian vessels and to occlude the uterine arteries. For this purpose, a small opening is made in the avascular place of the broad ligament on either side of the uterine isthmus superior to the uterine vessels. A pediatric Foley catheter is threaded through the two holes and tied tightly anteriorly around the cervix at the level of the internal os. Through the same openings in the broad ligament each side a Foley catheter looped around the infundibulopelvic ligament lateral to the fallopian tube and ovary. |
| PROCEDURE | Single tourniquet | Single tourniquet is tourniquet applied uterine isthmus to occlude the uterine arteries. For this purpose, a small opening is made in the avascular place of the broad ligament on either side of the uterine isthmus superior to the uterine vessels. A pediatric Foley catheter is threaded through the two holes and tied tightly anteriorly around the cervix at the level of the internal os. |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2014-01-30
- Last updated
- 2014-12-23
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02049242. Inclusion in this directory is not an endorsement.